Annual Current Liabilities
N/A
December 1, 2024
Summary
- PFE annual total current liabilities is not available.
Performance
PFE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
N/A
December 1, 2024
Summary
- PFE quarterly total current liabilities is not available.
Performance
PFE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PFE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.21 B(-1.4%) |
| Jun 2024 | - | $43.82 B(+8.2%) |
| Mar 2024 | - | $40.50 B(-15.3%) |
| Dec 2023 | $47.79 B(+13.4%) | $47.79 B(+53.5%) |
| Sep 2023 | - | $31.14 B(-10.1%) |
| Jun 2023 | - | $34.65 B(-5.2%) |
| Mar 2023 | - | $36.56 B(-13.2%) |
| Dec 2022 | $42.14 B(-1.2%) | $42.14 B(-4.9%) |
| Sep 2022 | - | $44.31 B(-6.5%) |
| Jun 2022 | - | $47.41 B(+20.7%) |
| Mar 2022 | - | $39.27 B(-8.0%) |
| Dec 2021 | $42.67 B(+64.6%) | $42.67 B(+2.1%) |
| Sep 2021 | - | $41.80 B(+17.2%) |
| Jun 2021 | - | $35.66 B(+33.8%) |
| Mar 2021 | - | $26.65 B(+2.8%) |
| Dec 2020 | $25.92 B(-30.5%) | $25.92 B(-24.1%) |
| Sep 2020 | - | $34.15 B(+4.4%) |
| Jun 2020 | - | $32.72 B(-3.4%) |
| Mar 2020 | - | $33.89 B(-9.2%) |
| Dec 2019 | $37.30 B(+17.1%) | $37.30 B(+0.9%) |
| Sep 2019 | - | $36.97 B(+15.4%) |
| Jun 2019 | - | $32.03 B(+8.9%) |
| Mar 2019 | - | $29.42 B(-7.6%) |
| Dec 2018 | $31.86 B(+4.7%) | $31.86 B(+9.8%) |
| Sep 2018 | - | $29.01 B(-9.8%) |
| Jun 2018 | - | $32.16 B(+17.5%) |
| Mar 2018 | - | $27.36 B(-10.1%) |
| Dec 2017 | $30.43 B(-2.2%) | $30.43 B(+7.8%) |
| Sep 2017 | - | $28.22 B(+3.8%) |
| Jun 2017 | - | $27.18 B(+9.3%) |
| Mar 2017 | - | $24.86 B(-20.1%) |
| Dec 2016 | $31.11 B(+5.8%) | $31.11 B(-10.5%) |
| Sep 2016 | - | $34.76 B(+8.3%) |
| Jun 2016 | - | $32.10 B(+11.7%) |
| Mar 2016 | - | $28.73 B(-2.3%) |
| Dec 2015 | $29.40 B(+36.2%) | $29.40 B(+5.6%) |
| Sep 2015 | - | $27.84 B(+15.3%) |
| Jun 2015 | - | $24.14 B(+19.4%) |
| Mar 2015 | - | $20.22 B(-6.3%) |
| Dec 2014 | $21.59 B(-7.6%) | $21.59 B(+8.4%) |
| Sep 2014 | - | $19.92 B(-9.2%) |
| Jun 2014 | - | $21.94 B(-11.5%) |
| Mar 2014 | - | $24.79 B(+6.1%) |
| Dec 2013 | $23.37 B(-19.9%) | $23.37 B(+14.7%) |
| Sep 2013 | - | $20.37 B(-13.1%) |
| Jun 2013 | - | $23.45 B(-14.9%) |
| Mar 2013 | - | $27.54 B(-5.6%) |
| Dec 2012 | $29.19 B(+1.0%) | $29.19 B(+0.2%) |
| Sep 2012 | - | $29.13 B(-5.4%) |
| Jun 2012 | - | $30.80 B(+13.7%) |
| Mar 2012 | - | $27.09 B(-6.3%) |
| Dec 2011 | $28.91 B(+1.0%) | $28.91 B(+3.8%) |
| Sep 2011 | - | $27.86 B(-8.6%) |
| Jun 2011 | - | $30.47 B(+4.5%) |
| Mar 2011 | - | $29.17 B(+2.0%) |
| Dec 2010 | $28.61 B(-23.1%) | $28.61 B(+18.4%) |
| Sep 2010 | - | $24.17 B(-2.1%) |
| Jun 2010 | - | $24.68 B(-4.8%) |
| Mar 2010 | - | $25.92 B(-30.4%) |
| Dec 2009 | $37.23 B(+37.8%) | $37.23 B(+55.2%) |
| Sep 2009 | - | $23.99 B(-8.1%) |
| Jun 2009 | - | $26.11 B(+11.9%) |
| Mar 2009 | - | $23.34 B(-13.6%) |
| Dec 2008 | $27.01 B(+23.7%) | $27.01 B(+25.6%) |
| Sep 2008 | - | $21.50 B(-7.3%) |
| Jun 2008 | - | $23.19 B(+7.0%) |
| Mar 2008 | - | $21.68 B(-0.7%) |
| Dec 2007 | $21.84 B(-1.2%) | $21.84 B(+52.4%) |
| Sep 2007 | - | $14.33 B(-5.3%) |
| Jun 2007 | - | $15.14 B(+13.8%) |
| Mar 2007 | - | $13.30 B(-39.8%) |
| Dec 2006 | $22.10 B | $22.10 B(+24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $17.69 B(-11.8%) |
| Jun 2006 | - | $20.05 B(+1.9%) |
| Mar 2006 | - | $19.67 B(-30.8%) |
| Dec 2005 | $28.41 B(+7.4%) | $28.41 B(+39.3%) |
| Sep 2005 | - | $20.39 B(-9.6%) |
| Jun 2005 | - | $22.57 B(-22.0%) |
| Mar 2005 | - | $28.95 B(+9.4%) |
| Dec 2004 | $26.46 B(+10.7%) | $26.46 B(+4.8%) |
| Sep 2004 | - | $25.24 B(+0.3%) |
| Jun 2004 | - | $25.16 B(+2.1%) |
| Mar 2004 | - | $24.64 B(+3.0%) |
| Dec 2003 | $23.91 B(+28.9%) | $23.91 B(+10.4%) |
| Sep 2003 | - | $21.66 B(-2.2%) |
| Jun 2003 | - | $22.16 B(+18.1%) |
| Mar 2003 | - | $18.75 B(+1.1%) |
| Dec 2002 | $18.55 B(+35.2%) | $18.55 B(+0.8%) |
| Sep 2002 | - | $18.40 B(+12.8%) |
| Jun 2002 | - | $16.32 B(+10.8%) |
| Mar 2002 | - | $14.73 B(+7.3%) |
| Dec 2001 | $13.73 B(+14.6%) | $13.73 B(+5.3%) |
| Sep 2001 | - | $13.04 B(+8.8%) |
| Jun 2001 | - | $11.98 B(+10.2%) |
| Mar 2001 | - | $10.87 B(-9.2%) |
| Dec 2000 | $11.98 B(+0.7%) | $11.98 B(-2.9%) |
| Sep 2000 | - | $12.34 B(+1.0%) |
| Jun 2000 | - | $12.22 B(+63.4%) |
| Mar 2000 | - | $7.48 B(-37.1%) |
| Dec 1999 | $11.90 B(+65.4%) | $11.90 B(+30.8%) |
| Sep 1999 | - | $9.09 B(+3.2%) |
| Jun 1999 | - | $8.81 B(+13.6%) |
| Mar 1999 | - | $7.75 B(+7.8%) |
| Dec 1998 | $7.19 B(+44.0%) | $7.19 B(-0.9%) |
| Sep 1998 | - | $7.26 B(+18.3%) |
| Jun 1998 | - | $6.14 B(+8.0%) |
| Mar 1998 | - | $5.68 B(+13.8%) |
| Dec 1997 | $4.99 B(-11.5%) | $4.99 B(-13.6%) |
| Sep 1997 | - | $5.78 B(-10.0%) |
| Jun 1997 | - | $6.42 B(+11.1%) |
| Mar 1997 | - | $5.78 B(+2.5%) |
| Dec 1996 | $5.64 B(+8.7%) | $5.64 B(-9.0%) |
| Sep 1996 | - | $6.20 B(+6.0%) |
| Jun 1996 | - | $5.85 B(+6.7%) |
| Mar 1996 | - | $5.48 B(+5.7%) |
| Dec 1995 | $5.19 B(+7.5%) | $5.19 B(-10.6%) |
| Sep 1995 | - | $5.80 B(-5.0%) |
| Jun 1995 | - | $6.10 B(+5.6%) |
| Mar 1995 | - | $5.78 B(+19.7%) |
| Dec 1994 | $4.83 B(+40.1%) | $4.83 B(+16.6%) |
| Sep 1994 | - | $4.14 B(-3.4%) |
| Jun 1994 | - | $4.29 B(+14.3%) |
| Mar 1994 | - | $3.75 B(+8.9%) |
| Dec 1993 | $3.44 B(+7.0%) | $3.44 B(-16.9%) |
| Sep 1993 | - | $4.15 B(+1.2%) |
| Jun 1993 | - | $4.10 B(+13.3%) |
| Mar 1993 | - | $3.62 B(+12.4%) |
| Dec 1992 | $3.22 B(-5.9%) | $3.22 B(-0.2%) |
| Sep 1992 | - | $3.22 B(+2.1%) |
| Jun 1992 | - | $3.16 B(+3.7%) |
| Mar 1992 | - | $3.05 B(-10.9%) |
| Dec 1991 | $3.42 B(+9.7%) | $3.42 B(+6.0%) |
| Sep 1991 | - | $3.23 B(-1.0%) |
| Jun 1991 | - | $3.26 B(+15.4%) |
| Mar 1991 | - | $2.83 B(-9.3%) |
| Dec 1990 | $3.12 B(+7.1%) | $3.12 B(+16.5%) |
| Sep 1990 | - | $2.68 B(+3.8%) |
| Jun 1990 | - | $2.58 B(+9.6%) |
| Mar 1990 | - | $2.35 B(-19.2%) |
| Dec 1989 | $2.91 B(+24.2%) | $2.91 B(+24.2%) |
| Dec 1988 | $2.34 B(+19.8%) | $2.34 B(+19.8%) |
| Dec 1987 | $1.96 B(+67.1%) | $1.96 B(+67.1%) |
| Dec 1986 | $1.17 B(+22.0%) | $1.17 B(+22.0%) |
| Dec 1985 | $959.70 M(-11.4%) | $959.70 M(-11.4%) |
| Dec 1984 | $1.08 B | $1.08 B |
FAQ
- What is the all time high annual current liabilities for Pfizer?
- What is the all time high quarterly current liabilities for Pfizer?
What is the all time high annual current liabilities for Pfizer?
Pfizer all-time high annual total current liabilities is $47.79 B
What is the all time high quarterly current liabilities for Pfizer?
Pfizer all-time high quarterly total current liabilities is $47.79 B